Skip to main content

CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.

Publication ,  Journal Article
Miura, S; Kawana, K; Schust, DJ; Fujii, T; Yokoyama, T; Iwasawa, Y; Nagamatsu, T; Adachi, K; Tomio, A; Tomio, K; Kojima, S; Yasugi, T ...
Published in: J Virol
November 2010

CD1d and CD1d-restricted natural killer T (NKT) cells serve as a natural bridge between innate and adaptive immune responses to microbes. CD1d downregulation is utilized by a variety of microbes to evade immune detection. We demonstrate here that CD1d is downregulated in human papillomavirus (HPV)-positive cells in vivo and in vitro. CD1d immunoreactivity was strong in HPV-negative normal cervical epithelium but absent in HPV16-positive CIN1 and HPV6-positive condyloma lesions. We used two cell lines for in vitro assay; one was stably CD1d-transfected cells established from an HPV-negative cervical cancer cell line, C33A (C33A/CD1d), and the other was normal human vaginal keratinocyte bearing endogenous CD1d (Vag). Flow cytometry revealed that cell surface CD1d was downregulated in both C33A/CD1d and Vag cells stably transfected with HPV6 E5 and HPV16 E5. Although the steady-state levels of CD1d protein decreased in both E5-expressing cell lines compared to empty retrovirus-infected cells, CD1d mRNA levels were not affected. Confocal microscopy demonstrated that residual CD1d was not trafficked to the E5-expressing cell surface but colocalized with E5 near the endoplasmic reticulum (ER). In the ER, E5 interacted with calnexin, an ER chaperone known to mediate folding of CD1d. CD1d protein levels were rescued by the proteasome inhibitor, MG132, indicating a role for proteasome-mediated degradation in HPV-associated CD1d downregulation. Taken together, our data suggest that E5 targets CD1d to the cytosolic proteolytic pathway by inhibiting calnexin-related CD1d trafficking. Finally, CD1d-mediated production of interleukin-12 from the C33A/CD1d cells was abrogated in both E5-expressing cell lines. Decreased CD1d expression in the presence of HPV E5 may help HPV-infected cells evade protective immunological surveillance.

Duke Scholars

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

November 2010

Volume

84

Issue

22

Start / End Page

11614 / 11623

Location

United States

Related Subject Headings

  • Virology
  • Papillomavirus Infections
  • Oncogene Proteins, Viral
  • Immune Evasion
  • Humans
  • Female
  • Down-Regulation
  • Cell Line, Tumor
  • Antigens, CD1d
  • Alphapapillomavirus
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Miura, S., Kawana, K., Schust, D. J., Fujii, T., Yokoyama, T., Iwasawa, Y., … Taketani, Y. (2010). CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV. J Virol, 84(22), 11614–11623. https://doi.org/10.1128/JVI.01053-10
Miura, Shiho, Kei Kawana, Danny J. Schust, Tomoyuki Fujii, Terufumi Yokoyama, Yuki Iwasawa, Takeshi Nagamatsu, et al. “CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.J Virol 84, no. 22 (November 2010): 11614–23. https://doi.org/10.1128/JVI.01053-10.
Miura S, Kawana K, Schust DJ, Fujii T, Yokoyama T, Iwasawa Y, Nagamatsu T, Adachi K, Tomio A, Tomio K, Kojima S, Yasugi T, Kozuma S, Taketani Y. CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV. J Virol. 2010 Nov;84(22):11614–11623.

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

November 2010

Volume

84

Issue

22

Start / End Page

11614 / 11623

Location

United States

Related Subject Headings

  • Virology
  • Papillomavirus Infections
  • Oncogene Proteins, Viral
  • Immune Evasion
  • Humans
  • Female
  • Down-Regulation
  • Cell Line, Tumor
  • Antigens, CD1d
  • Alphapapillomavirus